middle.news
Vitrafy Advances Platelet Cryopreservation with $32m Raise and US Blood Network Deals
8:29am on Wednesday 29th of July, 2026 AEST
•
Healthcare
Read Story
Vitrafy Advances Platelet Cryopreservation with $32m Raise and US Blood Network Deals
8:29am on Wednesday 29th of July, 2026 AEST
Key Points
94.4% post-thaw platelet recovery in US Army Phase II testing
Partnerships with Vitalant and Hoxworth blood centers
68% year-on-year growth in aquaculture cryopreservation throughput
$32 million capital raise supports US commercial build-out
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE